The immunocytokines market is estimated to be worth USD 5.4 billion in 2030, predicts Roots Analysis

Comments · 342 Views

Advances in molecular biology and tumor immunology have enabled the development of therapeutic fusion proteins, having the ability to activate immunologically cold microenvironments; this is achieved without the safety concerns associated with cytokine therapies

Roots Analysis is pleased to announce the publication of its recent study, titled, “Immunocytokines Market, 2021-2030.”

To order this 175+ page report, which features 95+ figures and 115+ tables, please visit https://www.rootsanalysis.com/reports/immunocytokines-market.html  

 

The report features an extensive study of the current and future potential of immunocytokines being developed for the treatment of rheumatoid arthritis and various types of cancer. In addition, it features an elaborate discussion on the likely future opportunity associated with such tools, over the next ten years. Amongst other elements, the report includes:

  • A detailed review of the current market landscape of immunocytokines
  • Tabulated profiles of prominent immunocytokine developers.
  • An analysis of recent developments in the field of immunocytokines.
  • An in-depth analysis of completed, ongoing, and planned clinical studies of various immunocytokines.
  • A list of key opinion leaders (KOLs) within this domain, and detailed 2×2 matrices to assess the relative experience of key individuals who were shortlisted based on their contribution (in terms of involvement in various clinical studies) to this field.
  • A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
  • Target Disease Indication 
  • Cervical Cancer
  • Cholangiocarcinoma
  • Esophageal Cancer
  • Gallbladder Cancer
  • Head and Neck Cancer
  • Melanoma
  • Non-small Cell Lung Cancer
  • Rheumatoid Arthritis
  • Soft Tissue Sarcoma

To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/immunocytokines-market/request-sample.html

 

  • Routes of Administration
  • Intravenous
  • Intratumoral
  • Subcutaneous
  • Key geographical regions
  • North America (US and Canada)
  • Europe (UK, Germany, Spain, France, and Italy)
  • Asia-Pacific (China, Japan, South Korea, and Australia)
  • Latin America (Brazil and Argentina)
  • Middle East and North Africa (Israel and Turkey)

 

For more information please click on the following link:

https://www.rootsanalysis.com/reports/immunocytokines-market.html

 

Other Recent Offerings

  1. Antisense Oligonucleotide Therapeutics Market, 2020-2030
  2. mRNA Therapeutics and Vaccines Market, 2020-2030
  3. Global T-Cell (CAR-T, TCR, and TIL) Therapies Market (5th Edition), 2021-2030

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis

Comments